NQO1 and neoplasm: NAD(P)H quinone oxidoreductase (NQO1), a cytoplasmic enzyme that mediates the reduction of quinone substrates, is highly expressed in a multitude of tumors and can catalyze quinone drugs to poison tumor cells (71).